Carcinoembryonic Antigen -- physiology : Cell adhesion and communication mediated by the CEA family : basic and clinical perspectives / edited by Clifford P. Stanners
Molecular products metabolized and secreted by neoplastic tissue and characterized biochemically in cells or BODY FLUIDS. They are indicators of tumor stage and grade as well as useful for monitoring responses to treatment and predicting recurrence. Many chemical groups are represented including HORMONES; ANTIGENS; amino and NUCLEIC ACIDS; ENZYMES; POLYAMINES; and specific CELL MEMBRANE PROTEINS and LIPIDS
Tests to experimentally measure the tumor-producing/cancer cell-producing potency of an agent by administering the agent (e.g., benzanthracenes) and observing the quantity of tumors or the cell transformation developed over a given period of time. The carcinogenicity value is usually measured as milligrams of agent administered per tumor developed. Though this test differs from the DNA-repair and bacterial microsome MUTAGENICITY TESTS, researchers often attempt to correlate the finding of carcinogenicity values and mutagenicity values
Tests to experimentally measure the tumor-producing/cancer cell-producing potency of an agent by administering the agent (e.g., benzanthracenes) and observing the quantity of tumors or the cell transformation developed over a given period of time. The carcinogenicity value is usually measured as milligrams of agent administered per tumor developed. Though this test differs from the DNA-repair and bacterial microsome MUTAGENICITY TESTS, researchers often attempt to correlate the finding of carcinogenicity values and mutagenicity values
The origin, production or development of cancer through genotypic and phenotypic changes which upset the normal balance between cell proliferation and cell death. Carcinogenesis generally requires a constellation of steps, which may occur quickly or over a period of many years
Carcinogenesis -- Animal models. : Animal models in cancer research and human disease : applications, outcomes and controversies / Sean A. Murray, editor
Carcinogenesis -- chemistry : The understanding, prevention and control of human cancer : the historic work and lives of Elizabeth Cavert Miller and James A. Miller / by Robert G. McKinnell
Carcinogenesis -- Genetic aspects : Regulation of carcinogenesis, angiogenesis and metastasis by the proprotein convertases (PCs) : a new potential strategy in cancer therapy / edited by A-Majid Khatib
Carcinogenesis -- Mathematical models -- Congresses : Mathematics, development biology, and tumour growth : UIMP-RSME Santaló Summer School, September 11-15, 2006, Universidad Internacional Menéndez Pelayo, Santander, Spain / Fernando Giraldez, Miguel A. Herrero, editors
Tests to experimentally measure the tumor-producing/cancer cell-producing potency of an agent by administering the agent (e.g., benzanthracenes) and observing the quantity of tumors or the cell transformation developed over a given period of time. The carcinogenicity value is usually measured as milligrams of agent administered per tumor developed. Though this test differs from the DNA-repair and bacterial microsome MUTAGENICITY TESTS, researchers often attempt to correlate the finding of carcinogenicity values and mutagenicity values
Tests to experimentally measure the tumor-producing/cancer cell-producing potency of an agent by administering the agent (e.g., benzanthracenes) and observing the quantity of tumors or the cell transformation developed over a given period of time. The carcinogenicity value is usually measured as milligrams of agent administered per tumor developed. Though this test differs from the DNA-repair and bacterial microsome MUTAGENICITY TESTS, researchers often attempt to correlate the finding of carcinogenicity values and mutagenicity values
Tests to experimentally measure the tumor-producing/cancer cell-producing potency of an agent by administering the agent (e.g., benzanthracenes) and observing the quantity of tumors or the cell transformation developed over a given period of time. The carcinogenicity value is usually measured as milligrams of agent administered per tumor developed. Though this test differs from the DNA-repair and bacterial microsome MUTAGENICITY TESTS, researchers often attempt to correlate the finding of carcinogenicity values and mutagenicity values
Tests to experimentally measure the tumor-producing/cancer cell-producing potency of an agent by administering the agent (e.g., benzanthracenes) and observing the quantity of tumors or the cell transformation developed over a given period of time. The carcinogenicity value is usually measured as milligrams of agent administered per tumor developed. Though this test differs from the DNA-repair and bacterial microsome MUTAGENICITY TESTS, researchers often attempt to correlate the finding of carcinogenicity values and mutagenicity values
Tests to experimentally measure the tumor-producing/cancer cell-producing potency of an agent by administering the agent (e.g., benzanthracenes) and observing the quantity of tumors or the cell transformation developed over a given period of time. The carcinogenicity value is usually measured as milligrams of agent administered per tumor developed. Though this test differs from the DNA-repair and bacterial microsome MUTAGENICITY TESTS, researchers often attempt to correlate the finding of carcinogenicity values and mutagenicity values
Tests to experimentally measure the tumor-producing/cancer cell-producing potency of an agent by administering the agent (e.g., benzanthracenes) and observing the quantity of tumors or the cell transformation developed over a given period of time. The carcinogenicity value is usually measured as milligrams of agent administered per tumor developed. Though this test differs from the DNA-repair and bacterial microsome MUTAGENICITY TESTS, researchers often attempt to correlate the finding of carcinogenicity values and mutagenicity values
1
Carcinogenicity : Overall evaluations of carcinogenicity : an updating of IARC monographs volumes 1 to 42 : this publication represents the views and expert opinions of an IARC ad-hoc Working Group on the Evaluation of Carcinogenic Risks to Humans, which met in Lyon, 10-18 March 1987
Carcinogenicity Arsenic : Human Exposure to Arsenic and Other Potentially Toxic Metals in Some Waters of Biu Volcanic Province, North-Eastern Nigeria
2014
1
Carcinogenicity Arsenic Congresses : Human Exposure to Arsenic and Other Potentially Toxic Metals in Some Waters of Biu Volcanic Province, North-Eastern Nigeria
Carcinogenicity Dapsone : Dapsone exposure and Australian Vietnam service : mortality and cancer incidence / [E J Wilson, K W Horsley, R. van der Hoek]
2007
1
Carcinogenicity Dioxins : Health risks from dioxin and related compounds : evaluation of the EPA reassessment / Committee on EPA's Exposure and Human Health Reassessment of TCDD and Related Compounds, Board on Environmental Studies and Toxicology, Division on Earth and Life Studies, National Research Council of the National Academies
Carcinogenicity Herbicides : Cancer hazards : parathion, malathion, diazanon, tetrachlorvinphos and glyphosate : the 2015 IARC classifications : implications for regulation, environmental justice, and global health / Martha Richmond
Carcinogenicity Hormones, Sex : Advances in rapid sex-steroid action : new challenges and new chances in breast and prostate cancers / Gabriella Castoria, Antimo Migliaccio, editors
2012
1
Carcinogenicity Hydrazines : Hydrazines and cancer : a guidebook on the carcinogenic activities of hydrazines, related chemicals, and hydrazine-containing natural products / Bela Toth
2000
1
Carcinogenicity Metals : The carcinogenicity of metals : Human risk through occupational and environmental exposure / Alan B.G. Lansdown
